Hirose, Toshiharu
Yamamoto, Shun
Honma, Yoshitaka
Yokoyama, Kazuki
Hirano, Hidekazu
Okita, Natsuko
Shoji, Hirokazu
Iwasa, Satoru
Takashima, Atsuo
Ishiyama, Koshiro
Oguma, Junya
Daiko, Hiroyuki
Maeda, Shin
Kato, Ken http://orcid.org/0000-0002-1733-5072
Article History
Received: 26 October 2023
Accepted: 8 February 2024
First Online: 12 March 2024
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.
: SY has received honoraria for lectures from Ono Pharmaceutical, Bristol-Myers Squibb, MSD, and Taiho Pharmaceutical [outside of the submitted work]. YH has received research grants and honoraria for lectures from Ono Pharmaceutical and Bristol Myers Squibb [outside of the submitted work]. SS has received research grants from AstraZeneca and honoraria for lectures from Roche and MSD [outside of the submitted work]. KK has received research grants and honoraria for lectures from Ono Pharmaceutical and Bristol-Myers Squibb [outside of the submitted work]. The other authors declare that they have no conflicts of interest.